Anupam Rasayan India Ltd. (ANURAS) AI Stock Analysis

• Market Cap: ₹123.66B
• Dividend Yield: 0.07%
• Average Volume (3M): 6.06K
• Price to Earnings (P/E): 100.1
• Beta (1Y): 0.74
• Revenue Growth: 24.37%
• EPS Growth: 29.89%
• Country: IN
• Employees: 1,896
• Sector: Basic Materials
• Sector Strength: 66
• Industry: Chemicals - Specialty
• EPS (TTM): 2.95
• Shares Outstanding: 109,931,335
• 10 Day Avg. Volume: 9,866
• 30 Day Avg. Volume: 6,059
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹911.50
• Price Target Upside: -18.97% Downside
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 2

• Rating: 64 Neutral
• Price Target: ₹1,198.00 ▲(6.50% Upside)

The stock score is driven primarily by decent technical momentum, with some concerns around high valuation and financial performance. The strong technical position provides a short-term positive outlook, but the high P/E ratio and cash flow challenges may pose long-term risks.

Anupam Rasayan India Ltd. Business Overview & Revenue Model

Company Description

Anupam Rasayan India Ltd. (ANURAS) is a leading specialty chemicals manufacturer based in India. The company primarily operates in the life sciences and other specialty chemical sectors, providing a wide range of products that cater to various industries, including agrochemicals, personal care, pharmaceuticals, and specialty pigments. Anupam Rasayan is known for its focus on complex and innovative chemistries, offering high-value products that serve as critical building blocks for its clients' products.

How the Company Makes Money

Anupam Rasayan India Ltd. generates revenue through the manufacturing and sale of specialty chemicals, which are used in various industries such as agrochemicals, pharmaceuticals, personal care, and more. The company's revenue model is centered around long-term contracts and strong relationships with its clients, which include multinational corporations. Key revenue streams for Anupam Rasayan include custom synthesis and contract manufacturing services, where the company develops and produces specialty chemicals according to client specifications. Additionally, the company benefits from strategic partnerships and a focus on research and development to innovate and expand its product offerings. By maintaining stringent quality standards and leveraging its expertise in complex chemistries, Anupam Rasayan secures a competitive edge in the market, contributing to its financial growth.

Anupam Rasayan India Ltd. Financial Statement Overview

Summary

Anupam Rasayan India Ltd. displays operational efficiency and a stable balance sheet but faces challenges in profitability and cash flow generation. The company must address revenue growth inconsistencies and improve cash flow management to enhance its financial health.

Income Statement

The company shows a stable gross profit margin but a declining net profit margin, indicating cost pressures or increased expenses. Revenue growth is inconsistent, with a decrease in the most recent year. EBIT and EBITDA margins are healthy, reflecting solid operational efficiency despite revenue fluctuations.

Balance Sheet

The debt-to-equity ratio indicates moderate leverage, which is manageable but has increased over time. Return on equity is positive but has shown a declining trend, suggesting reduced profitability. The equity ratio reflects a stable financial structure, providing some cushion against liabilities.

Cash Flow

The cash flow position is weak, with negative free cash flow growth and operating cash flow. The negative free cash flow to net income ratio highlights a potential issue in generating cash relative to earnings, indicating liquidity challenges.

Breakdown	TTM	Dec 2025	Dec 2023	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	14.38B	14.37B	16.02B	14.43B	10.57B	8.12B
Gross Profit	7.96B	8.32B	8.98B	3.76B	3.99B	2.71B
EBITDA	3.96B	4.01B	4.31B	4.01B	3.11B	2.17B
Net Income	933.48M	933.49M	1.81B	1.29B	1.52B	702.96M
Balance Sheet
Total Assets	52.69B	52.69B	37.78B	46.02B	28.91B	22.98B
Cash, Cash Equivalents and Short-Term Investments	1.35B	1.35B	6.67B	3.48B	618.77M	3.15B
Total Debt	13.73B	13.73B	8.22B	10.70B	8.36B	4.23B
Total Liabilities	21.87B	21.87B	12.70B	16.71B	11.64B	7.25B
Stockholders Equity	28.50B	28.50B	23.73B	27.61B	17.27B	15.73B
Cash Flow
Free Cash Flow	0.00	-4.40B	713.03M	-6.57B	-3.18B	-1.45B
Operating Cash Flow	0.00	-301.25M	2.92B	590.32M	-1.71B	14.59M
Investing Cash Flow	0.00	-3.30B	-5.23B	-3.92B	-4.12B	-1.93B
Financing Cash Flow	0.00	2.23B	3.71B	4.78B	3.84B	4.16B

Anupam Rasayan India Ltd. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1124.85
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ANURAS, the sentiment is Neutral. The current price of 1124.85 is below the 20-day moving average (MA) of 1135.61, below the 50-day MA of 1138.14, and above the 200-day MA of 872.06, indicating a neutral trend. The MACD of 0.44 indicates Positive momentum. The RSI at 46.82 is Neutral, neither overbought nor oversold. The STOCH value of 17.79 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:ANURAS.

Anupam Rasayan India Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TIMETECHNO	76 Outperform	₹105.07B	26.02		0.43%	8.49%	20.80%
PRIVISCL	66 Neutral	₹94.06B	43.07		0.21%	21.50%	78.82%
ANURAS	64 Neutral	₹123.66B	100.09		0.07%	24.37%	29.89%
JUBLINGREA	63 Neutral	₹116.28B	41.05		0.68%	2.60%	60.61%
Sector *	61 Neutral	$10.31B	6.18	0.76%	2.94%	3.30%	-36.34%
ALKYLAMINE	61 Neutral	₹105.76B	56.65		0.48%	10.29%	26.09%
GARFIBRES	61 Neutral	₹76.94B	32.34		0.19%	17.58%	14.66%